On Monday, Veracyte Inc (NASDAQ: VCYT) opened higher 6.61% from the last session, before settling in for the closing price of $36.48. Price fluctuations for VCYT have ranged from $18.61 to $41.43 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 34.42% annually for the last half of the decade. Company’s average yearly earnings per share was noted 129.41% at the time writing. With a float of $76.33 million, this company’s outstanding shares have now reached $77.50 million.
In an organization with 815 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.47%, operating margin of 2.6%, and the pretax margin is -1.92%.
Veracyte Inc (VCYT) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Veracyte Inc is 1.51%, while institutional ownership is 99.98%. The most recent insider transaction that took place on Sep 19 ’24, was worth 182,263. In this transaction Director of this company sold 5,173 shares at a rate of $35.23, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 04 ’24, when Company’s Chief Commercial Officer-CLIA sold 5,479 for $29.78, making the entire transaction worth $163,159. This insider now owns 76,174 shares in total.
Veracyte Inc (VCYT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.39 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.09) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 129.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.00% during the next five years compared to -10.52% drop over the previous five years of trading.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Check out the current performance indicators for Veracyte Inc (VCYT). In the past quarter, the stock posted a quick ratio of 4.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.92. Likewise, its price to free cash flow for the trailing twelve months is 52.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Veracyte Inc (VCYT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.19 million. That was better than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.85%. Additionally, its Average True Range was 1.56.
During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 88.29%, which indicates a significant increase from 73.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.82% in the past 14 days, which was lower than the 59.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.41, while its 200-day Moving Average is $25.81. However, in the short run, Veracyte Inc’s stock first resistance to watch stands at $39.57. Second resistance stands at $40.24. The third major resistance level sits at $41.56. If the price goes on to break the first support level at $37.58, it is likely to go to the next support level at $36.26. Assuming the price breaks the second support level, the third support level stands at $35.59.
Veracyte Inc (NASDAQ: VCYT) Key Stats
There are currently 76,812K shares outstanding in the company with a market cap of 2.94 billion. Presently, the company’s annual sales total 361,050 K according to its annual income of -74,400 K. Last quarter, the company’s sales amounted to 114,430 K and its income totaled 5,730 K.
